LEGGIO, GIAN MARCO
 Distribuzione geografica
Continente #
NA - Nord America 6.861
EU - Europa 3.678
AS - Asia 3.080
SA - Sud America 558
AF - Africa 398
Continente sconosciuto - Info sul continente non disponibili 267
OC - Oceania 6
Totale 14.848
Nazione #
US - Stati Uniti d'America 6.602
SG - Singapore 1.485
IT - Italia 1.360
RU - Federazione Russa 1.005
CN - Cina 849
BR - Brasile 472
IE - Irlanda 392
VN - Vietnam 240
UA - Ucraina 228
CI - Costa d'Avorio 215
CA - Canada 186
FR - Francia 148
KR - Corea 103
DE - Germania 102
SE - Svezia 88
GB - Regno Unito 83
IN - India 69
BD - Bangladesh 67
SN - Senegal 64
NG - Nigeria 55
NL - Olanda 53
HK - Hong Kong 41
FI - Finlandia 36
ES - Italia 35
PL - Polonia 35
MX - Messico 34
BE - Belgio 26
ID - Indonesia 26
JP - Giappone 26
TR - Turchia 25
ZA - Sudafrica 24
IQ - Iraq 22
AR - Argentina 21
PK - Pakistan 21
CO - Colombia 18
CH - Svizzera 16
IR - Iran 14
EC - Ecuador 13
UZ - Uzbekistan 13
LB - Libano 12
KE - Kenya 11
LT - Lituania 11
VE - Venezuela 11
AT - Austria 10
BJ - Benin 10
GR - Grecia 10
JM - Giamaica 10
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
DZ - Algeria 6
JO - Giordania 6
PH - Filippine 6
BG - Bulgaria 5
BO - Bolivia 5
CL - Cile 5
CR - Costa Rica 5
IL - Israele 5
KZ - Kazakistan 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
EU - Europa 4
GT - Guatemala 4
HN - Honduras 4
NP - Nepal 4
PE - Perù 4
SI - Slovenia 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
QA - Qatar 3
RO - Romania 3
TT - Trinidad e Tobago 3
DK - Danimarca 2
HR - Croazia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
SV - El Salvador 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BZ - Belize 1
ET - Etiopia 1
HU - Ungheria 1
LC - Santa Lucia 1
LU - Lussemburgo 1
Totale 14.580
Città #
Santa Clara 879
Singapore 855
Dallas 848
Houston 596
Chandler 469
Moscow 432
San Jose 411
Dublin 388
Catania 351
Ashburn 314
Jacksonville 299
Chicago 283
Abidjan 215
Boardman 167
Council Bluffs 162
Beijing 152
Hefei 151
Los Angeles 110
Lauterbourg 105
Andover 103
Cambridge 102
Seoul 102
Lawrence 101
Toronto 98
Nanjing 88
New York 87
Messina 81
Civitanova Marche 72
Des Moines 68
Ho Chi Minh City 67
Dakar 64
Hanoi 50
Palermo 46
Florence 45
Wilmington 42
Milan 40
São Paulo 39
Hong Kong 36
Ottawa 34
Amsterdam 33
Shenyang 32
The Dalles 32
Columbus 31
Rome 31
Hebei 30
Orem 30
Buffalo 29
Lagos 29
Bremen 27
Munich 27
Saint Petersburg 27
San Mateo 27
Montreal 26
Changsha 25
Jiaxing 25
Warsaw 25
Atlanta 24
Phoenix 24
Tianjin 24
Brooklyn 23
Falls Church 22
Nanchang 22
Seattle 22
Dong Ket 21
Tokyo 21
Rio de Janeiro 20
Abuja 19
Denver 19
Johannesburg 18
Kraainem 16
San Giovanni la Punta 16
Helsinki 15
Washington 15
Guangzhou 14
London 14
Naples 14
Poplar 14
Chennai 13
Dearborn 13
Grafing 13
Haiphong 13
Jakarta 13
Jinan 13
Mexico City 13
Philadelphia 13
San Francisco 13
Mascalucia 12
Baghdad 10
Belo Horizonte 10
Brussels 10
Cotonou 10
Curitiba 10
Lappeenranta 10
Redwood City 10
Stockholm 10
Zhengzhou 10
Aci Catena 9
Brasília 9
Lahore 9
Ankara 8
Totale 9.689
Nome #
Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus. 576
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 302
Current drug treatments targeting dopamine D3 receptor 253
Anthocyanin Effects on Vascular and Endothelial Health: Evidence from Clinical Trials and Role of Gut Microbiota Metabolites 250
Dopaminergic-GABAergic interplay and alcohol binge drinking 243
Blockade of dopamine D3 receptors improves hippocampal synaptic function and rescues age‐related cognitive phenotype 239
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 227
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 193
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 190
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 189
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 184
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 183
Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer’s disease 178
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 171
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 170
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 169
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 168
Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target 168
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 161
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 156
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside 153
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 153
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 150
Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT 148
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice 148
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 144
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 144
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 143
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 142
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 140
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 136
Epigenetic drugs for Alzheimer's disease: hopes and challenges 134
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 132
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 131
Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System 131
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 131
Retinal protection and distribution of curcumin in vitro and in vivo 131
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 130
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 130
Dopamine, cognitive impairments and second-generation antipsychotics: From mechanistic advances to more personalized treatments 130
APP expression in dopamine D3 receptor knock out mice brain during memory consolidation 127
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 125
P2X7 receptor antagonism: implications in diabetic retinopathy 125
Dopamine D3 receptor, neurofibromin and amyloid precursor protein expression during learning 125
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 125
Behavioral modifications induced by dietary cholesterol in rats 125
Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates 124
L'uso dell'acido alfa-lipoico in neurologia 123
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 122
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 122
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 122
Anthocyanin metabolites from gut microbiota and cognitive health 120
PLGA-PEG NANOPARTICLES LOADED WITH ANTIPSYCHOTIC AGENTS: INFLUENCE OF DRUG MOLECULES ON THE CRYOPROTECTIVE EFFECT OF SUCROSE 120
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System 116
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 115
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 113
Cortico-cortical transfer of socially derived information gates emotion recognition 111
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 110
Dopamine D3 receptor knockout mice exhibit increased hippocampal cAMP response element binding protein (CREB) following acquisition of passive avoidance memory 109
Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate 107
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 106
Pharmacological and genetic evidence of dopamine receptor 3-mediated vasoconstriction in isolated mouse aorta 105
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 105
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 103
Polyphenols and neuroprotection: Therapeutic implications for cognitive decline 102
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 101
Prenatal stress induces a depressive-like phenotype in adolescent rats: The key role of TGF-β1 pathway 99
The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain 99
Hippocampal neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice following passive avoidance conditioning. 98
Acute stress alters recognition memory and AMPA/NMDA receptor subunits in a sex-dependent manner 96
Dopamine-3 receptor modulates intraocular pressure: implications for glaucoma 96
New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease-modifying drugs 95
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 94
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: Focus on brexpiprazole and pimavanserin 94
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 93
Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia 91
Tackling dipeptidyl peptidase IV in neurological disorders 91
Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women 90
Oral Echinacea purpurea extract in low-grade, steroid-dependent, autoimmune idiopathic uveitis: a pilot study 88
Effects of citalopram combined with memantine in forced swimming test in rats 88
Ultra-Processed Food Consumption and Depressive Symptoms in a Mediterranean Cohort 87
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 87
Enhanced expression of PACAP and of its high affinity receptor (PAC1) in the hippocampus and cerebral cortex of dopamine D3 knockout mice. 87
Clinical pharmacology of novel anti-Alzheimer disease modifying medications. 87
Dopamine D3 receptor modulates tissue type plasminogen activator (tPA) activity in mouse brain 86
Physiological and therapeutic relevance of constitutive activity at 5HT2C receptors 85
Flavopiridol, an inhibitor of cyclin-dependent kinase 4, reverses cognitive deficits induced by β-amyloid peptide 1–42 85
Effects Of COOH-terminal tripeptide alpha-MSH (11-13) on corneal epithelial wound healing:role of nitric oxide 84
New drugs in psychiatry: Focus on new pharmacological targets 84
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 82
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 82
In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist 80
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 80
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 79
Parkin expression profile in dopamine d3 receptor knock-out mice brains 78
Increased hippocampal CREB phosphorylation in dopamine D3 receptor knockout mice following passive avoidance conditioning. 78
Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophrenia 77
Serotonin(2C) receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens 77
Neurofibromin and amyloid precursor protein expression in dopamine d3 receptor knock-out mice brains 77
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 77
Totale 13.110
Categoria #
all - tutte 49.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022639 0 0 15 18 134 45 113 27 63 7 33 184
2022/20231.422 115 92 18 163 143 214 17 263 325 6 41 25
2023/2024671 44 80 42 33 24 165 10 54 3 21 117 78
2024/20253.114 57 436 154 242 694 432 115 154 221 219 212 178
2025/20265.970 346 292 976 425 834 1.161 651 116 356 313 354 146
2026/2027602 308 260 34 0 0 0 0 0 0 0 0 0
Totale 14.848